IMPC Gene variants with decreased circulating fructosamine level
Total number of significant genotype-phenotype associations: 97
Gene / Allele | Zygosity | Sex | Life Stage | Phenotype | Parameter | Phenotyping Center |
P Value |
---|---|---|---|---|---|---|---|
Ap2a2 Ap2a2tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
0.00 | |
Tnip1 Tnip1tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.54×10-21 | |
Pank3 Pank3tm1b(KOMP)Mbp |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
9.82×10-18 | |
Arpc1b Arpc1btm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.84×10-13 | |
Irgm1 Irgm1em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.46×10-13 | |
Cxcr2 Cxcr2tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.08×10-12 | |
Itch Itchtm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
2.72×10-11 | |
Comt Comttm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
4.61×10-11 | |
Vps13c Vps13ctm1b(EUCOMM)Hmgu |
HOM | Late adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.87×10-10 | |
Snx8 Snx8tm2a(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.44×10-10 | |
Col4a5 Col4a5tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
3.67×10-10 | |
Tmco2 Tmco2tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.96×10-09 | |
Tex261 Tex261tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
4.66×10-09 | |
Myl12b Myl12btm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI MGP |
6.89×10-09 | |
Plekhm2 Plekhm2tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI EuroPhenome |
1.14×10-08 | |
Gdap2 Gdap2em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.32×10-08 | |
Vgf Vgfem1(IMPC)H |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.53×10-08 | |
Dcbld2 Dcbld2tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.41×10-08 | |
Fbxo7 Fbxo7tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
6.07×10-08 | |
Pfn1 Pfn1tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI MGP |
7.16×10-08 | |
4933402N03Rik 4933402N03Riktm2a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.29×10-07 | |
Clpp Clpptm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.48×10-07 | |
Usp54 Usp54tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
4.20×10-07 | |
Hddc2 Hddc2em1(IMPC)H |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
4.26×10-07 | |
Zranb2 Zranb2tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Creatine kinase Clinical Chemistry |
WTSI EuroPhenome |
4.61×10-07 | |
4933434E20Rik 4933434E20Riktm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
4.74×10-07 | |
Gmip Gmiptm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
5.53×10-07 | |
Syt4 Syt4em2(IMPC)H |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
7.31×10-07 | |
Tff1 Tff1tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
8.11×10-07 | |
Slc7a8 Slc7a8tm2b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
8.40×10-07 | |
Arhgap17 Arhgap17tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
8.74×10-07 | |
Prkaa2 Prkaa2tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
9.12×10-07 | |
Hexb Hexbtm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.08×10-06 | |
Jmjd4 Jmjd4em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.20×10-06 | |
Col4a2 Col4a2em1(IMPC)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.93×10-06 | |
Tbc1d22a Tbc1d22atm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.16×10-06 | |
Zmym4 Zmym4em1(IMPC)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.23×10-06 | |
Pam Pamem1(IMPC)Hmgu |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
2.52×10-06 | |
Man2b2 Man2b2tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.66×10-06 | |
Micu2 Micu2tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.71×10-06 | |
Sik3 Sik3tm1a(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.93×10-06 | |
Ap3s2 Ap3s2tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
3.50×10-06 | |
Pdgfrb Pdgfrbtm1b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
3.52×10-06 | |
Commd9 Commd9tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
4.77×10-06 | |
Map3k1 Map3k1tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
5.16×10-06 | |
Eps8l2 Eps8l2tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
5.38×10-06 | |
Cbr2 Cbr2tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
5.76×10-06 | |
Col4a5 Col4a5tm1b(EUCOMM)Wtsi |
HEM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
6.82×10-06 | |
Nedd1 Nedd1em1(IMPC)H |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
7.65×10-06 | |
Peds1 Peds1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
7.66×10-06 | |
Galnt18 Galnt18tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
7.66×10-06 | |
Slc7a2 Slc7a2tm1b(EUCOMM)Hmgu |
HOM | Late adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
8.03×10-06 | |
Armc2 Armc2tm1b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.08×10-05 | |
Tmem51 Tmem51tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.10×10-05 | |
Pes1 Pes1tm1b(EUCOMM)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.23×10-05 | |
Fcho2 Fcho2tm1b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.31×10-05 | |
Tmem178b Tmem178btm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.43×10-05 | |
Ccdc127 Ccdc127tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.46×10-05 | |
Med23 Med23em1(IMPC)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.56×10-05 | |
Actl10 Actl10tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.64×10-05 | |
Dynll1 Dynll1tm1(KOMP)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.66×10-05 | |
P3h2 P3h2em1(IMPC)H |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.95×10-05 | |
Slc16a2 Slc16a2tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI MGP |
1.97×10-05 | |
Nhp2 Nhp2tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.79×10-05 | |
Csnk1g3 Csnk1g3tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.86×10-05 | |
Dbn1 Dbn1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI MGP |
2.87×10-05 | |
Ampd2 Ampd2tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
3.37×10-05 | |
Usp21 Usp21tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
3.38×10-05 | |
Susd6 Susd6tm1b(KOMP)Wtsi |
HOM | Late adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
3.46×10-05 | |
Wrap53 Wrap53tm1b(EUCOMM)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
3.59×10-05 | |
Ceacam3 Ceacam3em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
3.72×10-05 | |
Aff3 Aff3tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
3.74×10-05 | |
Cabp1 Cabp1tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
3.82×10-05 | |
Slc5a7 Slc5a7tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
3.88×10-05 | |
Izumo1r Izumo1rtm2a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
4.45×10-05 | |
Usp15 Usp15tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
5.32×10-05 | |
Ccdc122 Ccdc122tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
5.44×10-05 | |
Ppy Ppytm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
HMGU IMPC |
6.31×10-05 | |
Slc17a7 Slc17a7em1(IMPC)H |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
6.34×10-05 | |
Gsk3a Gsk3atm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI MGP |
6.53×10-05 | |
Atxn3 Atxn3tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
6.98×10-05 | |
Gda Gdatm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
7.15×10-05 | |
Vil1 Vil1em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
7.32×10-05 | |
Arhgap30 Arhgap30tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
7.72×10-05 | |
Ifnar1 Ifnar1tm2a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
8.09×10-05 | |
Sag Sagtm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
9.45×10-05 |